These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8419074)

  • 1. Effect of chlorpromazine on kinetics of injected monoclonal antibody in MoAb-induced glomerular injury.
    Takashima N; Kawachi H; Oite T; Nishi S; Arakawa M; Shimizu F
    Clin Exp Immunol; 1993 Jan; 91(1):135-40. PubMed ID: 8419074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
    Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
    J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain variation in susceptibility to the development of monoclonal antibody 5-1-6-induced proteinuria in rats.
    Gollner D; Kawachi H; Oite T; Oka M; Nagase M; Shimizu F
    Clin Exp Immunol; 1995 Aug; 101(2):341-5. PubMed ID: 7648719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute glomerulonephritis after intravenous injection of monoclonal anti-thymocyte antibodies in the rat.
    Bagchus WM; Hoedemaeker PJ; Rozing J; Bakker WW
    Immunol Lett; 1986 Mar; 12(2-3):109-13. PubMed ID: 3522413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.
    Singh AK; Kasinath BS
    Clin Exp Immunol; 1993 Dec; 94(3):403-11. PubMed ID: 8252800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
    Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
    Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative studies of monoclonal antibody 5-1-6-induced proteinuric state in rats.
    Kawachi H; Matsui K; Orikasa M; Morioka T; Oite T; Shimizu F
    Clin Exp Immunol; 1992 Feb; 87(2):215-9. PubMed ID: 1735184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals.
    Salant DJ; Darby C; Couser WG
    J Clin Invest; 1980 Jul; 66(1):71-81. PubMed ID: 7400310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chlorpromazine on the development of experimental glomerulonephritis and Arthus reaction.
    Camussi G; Salvidio G; Niesen N; Brentjens J; Andres G
    Am J Pathol; 1988 Jun; 131(3):418-34. PubMed ID: 2968048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Il-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells.
    Spicer ST; Ha H; Boyd RA; He XY; Carter N; Tran G; Penny MJ; Hodgkinson SJ; Hall BM
    J Immunol; 2001 Oct; 167(7):3725-33. PubMed ID: 11564788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigen.
    Kawachi H; Orikasa M; Matsui K; Iwanaga T; Toyabe S; Oite T; Shimizu F
    Clin Exp Immunol; 1992 Jun; 88(3):399-404. PubMed ID: 1376651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divalency of the monoclonal antibody 5-1-6 is required for induction of proteinuria in rats.
    Narisawa M; Kawachi H; Oite T; Shimizu F
    Clin Exp Immunol; 1993 Jun; 92(3):522-6. PubMed ID: 8513584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative study of mesangial injury with proteinuria induced by monoclonal antibody 1-22-3.
    Kawachi H; Oite T; Shimizu F
    Clin Exp Immunol; 1993 May; 92(2):342-6. PubMed ID: 8485919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats.
    Salant DJ; Belok S; Stilmant MM; Darby C; Couser WG
    Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis.
    Nakazawa M; Emancipator SN; Lamm ME
    J Exp Med; 1986 Dec; 164(6):1973-87. PubMed ID: 3537193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new role for complement in experimental membranous nephropathy in rats.
    Salant DJ; Belok S; Madaio MP; Couser WG
    J Clin Invest; 1980 Dec; 66(6):1339-50. PubMed ID: 7440718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephritogenic glycoprotein. XI. Comparison of humoral immune responses in rats injected with nephritogenoside and those given Heymann antigen.
    Aotsuka S; Shibata S
    Nephron; 1987; 47(2):95-100. PubMed ID: 3696324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody to brush border and passive Heymann nephritis.
    Ronco P; Allegri L; Melcion C; Pirotsky E; Appay MD; Bariety J; Pontillon F; Verroust P
    Clin Exp Immunol; 1984 Feb; 55(2):319-32. PubMed ID: 6365376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.